On October 23, 2009, Nuvilex, Inc. accepted the resignation of Robert J. Creeden as a member of the company's Board of Directors. Mr. Creeden has submitted his resignation due to policies set by Partners Innovation Fund and its parent, Partners Healthcare regarding the holding of board seats for publicly traded companies. Mr. Creeden served as a member of the board of directors of Freedom2 and agreed to join the company's board to provide some continuity during the transition period.

Nuvilex, Inc. announced that it has received the final report from its Phase 2 microplot trials investigating the use of Oraphyte(TM) as an all-natural, eco-friendly nematocide for the turfgrass market with results supporting the commercial viability of the product. Over the past three years, nematologist and plant pathologist Edward McGawley, Ph.D. of the Louisiana State University's Agricultural Center (LSU AgCenter) has investigated the use of Oraphyte(TM) on several species of turfgrass, including St. Augustine turfgrass (Stenotaphrum secundatum), bermudagrass (Cynodon dactylon), and creeping bentgrass (Agrostis). During the summer of 2009, Dr. McGawley and his team of researchers applied Oraphyte(TM) to the soil of microplots that contained bermudagrass and creeping bentgrass. The primary goals of the Phase 2 microplot trials were to determine if Oraphyte(TM) could substantially reduce the populations of six nematode genera while causing minimal damage to the blades and root structures of turfgrass. Results from the Phase 2 microplot trials indicate that one treatment of 7% Oraphyte(TM) is able to reduce the nematode population while causing little or no damage to the blades and root structures of turfgrass. Further turf studies with Oraphyte(TM) are underway in a recreational golf environment.

Effective September 18, 2009, Nuvilex Inc. will change its OTCBB stock ticker symbol to NVLXE from NVLX.